Skip to main content

Biomarin Pharmaceuticals(BMRN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

BioMarin Announces Strong Second Quarter 2023 Results and Record Breaking Revenues for the First Half of 2023, Including 13% Year Over Year Growth Year-to-date

PR Newswire - Mon Jul 31, 2023

Financial Highlights (in millions of U.S. dollars, except per share data, unaudited)

Three Months Ended

June 30,

Six Months Ended

June 30,

2023

2022

% Change

2023

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe